// App-Quantinova.ai

1038 : Impact of delayed neoadjuvant systemic chemotherapy on survival outcomes in breast cancer patients.

Researchers

Presenter

  • Rachel Ann Sanford

Principal Investigators

  • Xiudong Lei

  • Sharon Hermes Giordano

  • Debu Tripathy

  • Carlos Hernando Barcenas

  • Mariana Chavez-Mac Gregor

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Department of Health Services Research, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved